| scholarly article | Q13442814 |
| P50 | author | Monica Aasrum | Q95966225 |
| P2093 | author name string | Thoralf Christoffersen | |
| G Hege Thoresen | |||
| Ingvild J Brusevold | |||
| P2860 | cites work | Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI‐3 kinase/Akt | Q39380720 |
| SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes. | Q39957327 | ||
| Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation | Q40051472 | ||
| Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells. | Q40202337 | ||
| Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate | Q40244502 | ||
| MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1. | Q40799925 | ||
| High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors | Q40812213 | ||
| The Raf-1/MEK/ERK pathway regulates the expression of the p21(Cip1/Waf1) gene in chondrocytes | Q40924273 | ||
| Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation | Q40975219 | ||
| Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. | Q41173912 | ||
| Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes | Q42457194 | ||
| Hepatocyte growth factor stimulates cell growth and enhances the expression of transforming growth factor alpha mRNA in AsPC-1 human pancreatic cancer cells | Q42476349 | ||
| Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. | Q43890944 | ||
| The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylation | Q44023068 | ||
| Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor | Q44164603 | ||
| Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure | Q44322676 | ||
| Role of ERK, p38 and PI3-kinase in EGF receptor-mediated mitogenic signalling in cultured rat hepatocytes: requirement for sustained ERK activation | Q44522579 | ||
| p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation | Q47677865 | ||
| Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. | Q50749097 | ||
| HGF-induced DNA synthesis in hepatocytes is suppressed by p38. | Q53657877 | ||
| Genetics and Biology of Pancreatic Ductal Adenocarcinoma | Q54255820 | ||
| ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. | Q54704420 | ||
| The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes. | Q54761450 | ||
| Stimulation of hepatocyte DNA synthesis by prostaglandin E2 and prostaglandin F2 alpha: additivity with the effect of norepinephrine, and synergism with epidermal growth factor | Q72317104 | ||
| Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis, and signal transduction of primary rat hepatocytes | Q72809767 | ||
| Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells | Q74366561 | ||
| One-way cross-talk between p38(MAPK) and p42/44(MAPK). Inhibition of p38(MAPK) induces low density lipoprotein receptor expression through activation of the p42/44(MAPK) cascade | Q77955135 | ||
| The p38 transduction pathway in prostatic neoplasia | Q82045634 | ||
| Pancreatic cancer | Q87198210 | ||
| The selectivity of protein kinase inhibitors: a further update | Q24654622 | ||
| Examination of the expanding pathways for the regulation of p21 expression and activity | Q27692024 | ||
| Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation | Q28131755 | ||
| A synthetic inhibitor of the mitogen-activated protein kinase cascade | Q28367955 | ||
| p21 in cancer: intricate networks and multiple activities | Q30436015 | ||
| Mist1 regulates pancreatic acinar cell proliferation through p21 CIP1/WAF1 | Q33783645 | ||
| Phenotype and genotype of pancreatic cancer cell lines | Q33814471 | ||
| The p38 signal transduction pathway: activation and function | Q33838955 | ||
| p38 MAP kinases: beyond the stress response | Q33934138 | ||
| Mechanisms and functions of p38 MAPK signalling. | Q34125736 | ||
| p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes | Q34415888 | ||
| Cell cycle regulation by p38 MAP kinases | Q34454899 | ||
| ERK implication in cell cycle regulation | Q34594561 | ||
| Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence | Q35174677 | ||
| p38 MAP kinase's emerging role as a tumor suppressor | Q35941622 | ||
| Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues | Q36101745 | ||
| MAPK signal specificity: the right place at the right time | Q36444123 | ||
| Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer | Q36547939 | ||
| Functional p38 MAPK identified by biomarker profiling of pancreatic cancer restrains growth through JNK inhibition and correlates with improved survival | Q36899872 | ||
| p38alpha: a suppressor of cell proliferation and tumorigenesis | Q36980265 | ||
| Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival | Q37015135 | ||
| Non-classical p38 map kinase functions: cell cycle checkpoints and survival | Q37374255 | ||
| Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study | Q37485098 | ||
| Signal integration by JNK and p38 MAPK pathways in cancer development | Q37560607 | ||
| p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells | Q38519488 | ||
| p21: A Two-Faced Genome Guardian. | Q38747952 | ||
| Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells | Q38834081 | ||
| P433 | issue | 4 | |
| P921 | main subject | pancreatic carcinoma | Q18556536 |
| P304 | page(s) | 699-707 | |
| P577 | publication date | 2018-01-29 | |
| P1433 | published in | Journal of Cell Communication and Signaling | Q26841964 |
| P1476 | title | p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines | |
| P478 | volume | 12 |
| Q90062138 | A Novel Tanshinone Analog Exerts Anti-Cancer Effects in Prostate Cancer by Inducing Cell Apoptosis, Arresting Cell Cycle at G2 Phase and Blocking Metastatic Ability | cites work | P2860 |
Search more.